XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.1
LIQUIDITY AND GOING CONCERN (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended 9 Months Ended
Feb. 20, 2025
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Proceeds from Issuance of Common Stock   $ 809,721   $ 1,486,340                
Payments for Commissions   $ 25,044   $ 45,971                
Stock Issued During Period, Shares, New Issues   481,996   920,363                
Net loss   $ 2,543,526 $ 2,977,667   $ 7,478,629 $ 7,372,512            
Shareholders' equity   4,943,766 $ 10,997,772 $ 4,943,766 4,943,766 $ 10,997,772 $ 4,203,388 $ 5,949,242 $ 8,183,191 $ 3,154,234 $ 1,236,558 $ 3,686,998
Working capital   542,946   542,946 542,946              
Accumulated deficit   59,442,961   59,442,961 59,442,961       $ 51,964,332      
Cash and cash equivalents   $ 2,810,000   $ 2,810,000 $ 2,810,000              
Over-Allotment Option [Member]                        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Exercised shares 2,645,000                      
Underwriting discounts and commissions $ 355,000                      
Underwriting Agreement [Member]                        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Stock Issued During Period, Shares, New Issues 1,304,348                      
Share Price $ 2.00                      
Stock Issued During Period, Shares, Purchase of Assets 1,304,348                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures 195,652                      
Shares Issued, Price Per Share $ 2.00                      
Exercised shares 195,652